Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway

Fig. 3

FC ameliorates the hepatic steatosis in HFD-induced obese mice. Histopathological analysis was exhibited via hematoxylin and eosin (H&E) staining A, and Oil-Red Stating B. HFD-induced liver steatosis obese mice showed abundant vacuoles lipid droplets in H & E staining (A, arrows) and oil red positive area in Oil-Red Staining (B, arrows). Simvastatin (Sim, 40 mg/kg) acted as the positive control group

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us